MOGLIA, Cristina
Dettaglio
MOGLIA, Cristina
NEUROSCIENZE "RITA LEVI MONTALCINI"
Pubblicazioni
Risultati 1 - 20 di 171 (tempo di esecuzione: 0.0 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | 18 F-FDG-PET correlates of cognitive impairment in ALS | 2016 | Canosa, Antonio; Pagani, Marco; Cistaro, Angelina; Montuschi, Anna; Iazzolino, Barbara; Fania, Piercarlo; Cammarosano, Stefania; Ilardi, Antonio; Moglia, Cristina; Calvo, Andrea; Chiò, Adriano |
2 | A Strange Loop: Effects of emotional facial expressions impaired recognition in ALS Patients and in their Caregivers. | 2012 | A. Montuschi; A. Lo Presti; C. Moglia; A. Calvo; M. Lo Russo; F. Casale; M. Tamietto; A. Chiò |
3 | A cluster of ALS Cases in Sardinia due to a founder mutation of the TARDBP gene | 2011 | Chio' A; Borghero G; Pugliatti M; Ticca A; Calvo A; Moglia C; brunetti M; Ossola I; Marrosu M; Murru MR; Floris G; Cannas A; Parish LD; Cossu p; Abramzon Y; Johnson JO; Arepalli S; Chong S; Hernandez DG; Traynor BJ; Restagno G |
4 | A de novo missense mutation of the FUS gene in a "true" sporadic ALS case | 2011 | Chiò A; Calvo A; Moglia C; Ossola I; Brunetti M; Sbaiz L; Lai SL; Abramzon Y; Traynor BJ; Restagno G |
5 | A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. | 2014 | A. Calvo;C. Moglia;A. Canosa;M. Brunetti;M. Barberis;B. J. Traynor;G. Carrara;C. Valentini;G. Restagno;A. Chiò |
6 | A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. | 2014 | A. Canosa;A. Calvo;C. Moglia;B. Iazzolino;M. Brunetti;G. Restagno;A. Cistaro;P. Fania;G. Carrara;M. C. Valentini;R. Tanel;A. Chiò |
7 | A longitudinal study on quality of life and depression in ALS patient-caregiver couples | 2007 | A. GAUTHIER; A. VIGNOLA; A. CALVO; E. CAVALLO; C. MOGLIA; L. SELLITTI; R. MUTANI; A. CHIO' |
8 | A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. | 2015 | A. Canosa;A. Calvo;C. Moglia;M. Barberis;M. Brunetti;S. Cammarosano;U. Manera;A. Ilardi;G. Restagno;A. Chiò |
9 | A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD | 2011 | Borghero G; Floris G; Cannas A; Marrosu MG; Murru MR; Costantino E; Parish LD; Pugliatti M; Ticca A; Traynor BJ; Calvo A; Cammarosano S; Moglia C; Cistaro A; Brunetti M; Restagno G; Chiò A |
10 | A phase I-II multicenter study on G-CSF in ALS: clinical and hematological results | 2009 | Moglia C; Calvo A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Corbo M; Mancardi GL; Tonali PA; Mutani R; Tarella C; Chio' A |
11 | A pilot trial of G-CSF in amyotrophic lateral sclerosis | 2008 | Chio' A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Moglia C; Mancardi GL; Tonali P; Calvo A; Mutani R; Corbo M; Scime’ R; D’Onofrio G; Petrini M; Melazzini M. Gualandi F; Tarella C |
12 | Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis | 2020 | Cabras, Sara; Calvo, Andrea; Moglia, Cristina; Chiò, Adriano; Canosa, Antonio |
13 | ALS clinical trials: Do enrolled patients accurately represent the ALS population? | 2011 | Chiò A; Canosa A; Gallo S; Cammarosano S; Moglia C; Fuda G; Calvo A; Mora G; For the PARALS group |
14 | ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? | 2011 | Chio' A; Mora G; Moglia C; Fuda G; Canosa A; Gallo S; Cammarosano S; Ilardi A; Calvo A |
15 | ALS phenotype is influenced by age, sex, and genetics: A population-based study | 2020 | Chiò, Adriano; Moglia, Cristina; Canosa, Antonio; Manera, Umberto; D'Ovidio, Fabrizio; Vasta, Rosario; Grassano, Maurizio; Brunetti, Maura; Barberis, Marco; Corrado, Lucia; D'Alfonso, Sandra; Iazzolino, Barbara; Peotta, Laura; Sarnelli, Maria Francesca; Solara, Valentina; Zucchetti, Jean Pierre; De Marchi, Fabiola; Mazzini, Letizia; Mora, Gabriele; Calvo, Andrea |
16 | ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations | 2012 | Chio' A; Restagno G; Brunetti M; Ossola I; Calvo A; Canosa A; Moglia C; Floris G; Tacconi P; Marrosu F; Marrosu MG; Murru MR; Majounie E; Renton AE; Abramzon Y; Pugliatti M; Sotgiu MA; Traynor BJ; Borghero G |
17 | Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic | 2021 | Giusiano S.; Peotta L.; Iazzolino B.; Mastro E.; Arcari M.; Palumbo F.; Torrieri M.C.; Bombaci A.; Grassano M.; Cabras S.; Di Pede F.; De Mattei F.; Matteoni E.; Solero L.; Daviddi M.; Salamone P.; Fuda G.; Manera U.; Canosa A.; Chio A.; Calvo A.; Moglia C.; Vasta R. |
18 | Amyotrophic lateral sclerosis mimic syndrome due to a dorsal spinal cord neurofibroma | 2010 | A.Calvo; F.Benech; P.Ghiglione; M.Balma; C.Moglia; R.Mutani; A.Chio |
19 | Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. | 2015 | A. Canosa;A. Calvo;M. Barberis;M. Brunetti;G. Restagno;S. Cammarosano;A. Ilardi;M. C. Vigliani;A. Chiò;C. Moglia |
20 | Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study | 2014 | A. Chiò;A. Calvo;G. Bovio;A. Canosa;D. Bertuzzo;F. Galmozzi;P. Cugnasco;M. Clerico;S. De Mercanti;E. Bersano;S. Cammarosano;A. Ilardi;U. Manera;C. Moglia;R. Sideri;K. Marinou;E. Bottacchi;F. Pisano;R. Cantello;L. Mazzini;G. Mora; Piemonte;V. d. Register |